Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Kidney Allograft Nephropathy”

81 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 81 results

Large-scale testing (Phase 3)Study completedNCT00975000
What this trial is testing

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Who this might be right for
Chronic Allograft NephropathyChronic Kidney DiseaseChronic Renal Failure+7 more
Amgen 114
Testing effectiveness (Phase 2)Study completedNCT00446459
What this trial is testing

Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.

Who this might be right for
Kidney Failure, ChronicDiabetic NephropathiesGlomerulonephritis, IGA+1 more
University of Washington 45
Post-approval studies (Phase 4)Study completedNCT00282217
What this trial is testing

Study Evaluating Sirolimus in the Treatment of Kidney Transplant

Who this might be right for
Kidney FailureKidney Diseases
Wyeth is now a wholly owned subsidiary of Pfizer 100
Post-approval studies (Phase 4)Study completedNCT00188955
What this trial is testing

Pilot Study on the Use of Sirolimus to Treat Chronic Allograft Nephropathy in Children After Kidney Transplant

Who this might be right for
Kidney Transplantation
University of Manitoba 40
Post-approval studies (Phase 4)Study completedNCT00476164
What this trial is testing

Study of Rituximab to Treat Chronic Renal Transplant Rejection

Who this might be right for
Kidney TransplantationGraft RejectionImmunosuppression
King's College London 62
Post-approval studies (Phase 4)Study completedNCT00634920
What this trial is testing

Evaluation of Early Conversion to Everolimus From Cyclosporine in de Novo Renal Transplant Recipients

Who this might be right for
Renal Function
Novartis Pharmaceuticals 204
Large-scale testing (Phase 3)Study completedNCT00000935
What this trial is testing

An Evaluation of IV Gamma Globulin As a Method to Improve Kidney Transplant Survival in Patients With End-Stage Renal Disease Who Are Highly Sensitized to Transplant Antigens

Who this might be right for
End-Stage Renal DiseaseKidney Transplantation
National Institute of Allergy and Infectious Diseases (NIAID) 100
Large-scale testing (Phase 3)Not Yet RecruitingNCT07835581
What this trial is testing

Phase 3 Randomized Study of Tegoprubart Efficacy and Safety Compared With Tacrolimus in Kidney Transplantation

Who this might be right for
Kidney Transplant Rejection
Eledon Pharmaceuticals 620
Not applicableStudy completedNCT01346397
What this trial is testing

Study Cyclosporine (CsA) Versus Tacrolimus (Tacro) After Campath Induction in Kidney Transplantation

Who this might be right for
Acute Graft RejectionChronic Allograft NephropathyPolyomavirus-related Transplant Nephropathy
Russian Academy of Medical Sciences 170
Testing effectiveness (Phase 2)Looking for participantsNCT05027906
What this trial is testing

Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant

Who this might be right for
Prevention of Rejection in Kidney Transplant
Eledon Pharmaceuticals 48
Testing effectiveness (Phase 2)Ended earlyNCT00090194
What this trial is testing

Improving Transplant Options of Highly Sensitized Recipients Using IGIV-C, 10%

Who this might be right for
Kidney Failure, Chronic
National Institute of Allergy and Infectious Diseases (NIAID) 56
Not applicableEnrolling By InvitationNCT05058170
What this trial is testing

Renal Allograft Fibrosis Study

Who this might be right for
Renal Allograft Fibrosis
Icahn School of Medicine at Mount Sinai 162
Post-approval studies (Phase 4)UnknownNCT01510795
What this trial is testing

Mineralocorticoid Receptor Antagonist and Kidney Allograft Histology

Who this might be right for
Kidney Failure, Chronic
Clinical Hospital Merkur 40
Not applicableStudy completedNCT01289717
What this trial is testing

Proteogenomic Biomarker Panels in a Serial Blood & Urine Monitoring Study of Kidney Transplant Recipients

Who this might be right for
Kidney TransplantKidney Transplantation
National Institute of Allergy and Infectious Diseases (NIAID) 307
Not applicableStudy completedNCT03719339
What this trial is testing

VIRTUUS Children's Study

Who this might be right for
Renal Transplant RejectionPediatric Kidney DiseaseEnd Stage Renal Disease+4 more
Children's Hospital of Philadelphia 445
Not applicableStudy completedNCT01443013
What this trial is testing

Analysis of Foxp3 and Vimentin Expression in Renal Transplant Recipient

Who this might be right for
Function of Renal Transplant
Assistance Publique - Hôpitaux de Paris 266
Not applicableLooking for participantsNCT01531257
What this trial is testing

Proteogenomic Monitoring and Assessment of Kidney Transplant Recipients

Who this might be right for
Acute Rejection (AR) of Transplanted KidneyChronic Allograft Nephropathy (CAN)Interstitial Fibrosis (IF)+1 more
Northwestern University 1,000
Large-scale testing (Phase 3)Ended earlyNCT00005113
What this trial is testing

Compare Treatment With Sirolimus Versus Standard Treatment in Patients Who Have Received a Kidney Transplant

Who this might be right for
End-Stage Renal DiseaseKidney Transplantation
Boston Children's Hospital 102
Not applicableLooking for participantsNCT05880537
What this trial is testing

Decellularized Femoral Artery Allograft (Nexeon AVX) Prospective Registry

Who this might be right for
End-Stage Renal Disease
LifeNet Health 100
Large-scale testing (Phase 3)Ended earlyNCT01636466
What this trial is testing

The Everolimus-Transplant Exit Strategy Trial (E-TEST)

Who this might be right for
Kidney Failure, Chronic
Ashtar Chami 1
Next Page